Eli Lilly did not immediately respond to a request for comment
Risk factors that might warrant consideration of medication adjustment include: Recent initiation or dose escalation of GLP-1 therapy Significant gastrointestinal symptoms (nausea, vomiting, early satiety) Maximum medication doses Known gastroparesis or other conditions affecting gastric emptying For patients where holding the medication is deemed appropriate, the duration should be individualized based on the specific medication, patient factors, and clinical judgment
Nutrient density : with reduced overall food intake, every bite needs to deliver nutritional value
Real-world data from compounding pharmacy patients using semaglutide show an average systolic drop of 48 mmHg within 12 weeks, with some individuals experiencing reductions exceeding 15 mmHg
It is also worth noting that both of the other conditions discussed today, diabetes and thyroid disease, can increase the risk of osteoporosis